Related Experiment Video
Updated: Aug 15, 2026
05:41
Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions
Published on: February 9, 2024
Abnormal TSH: a rational approach to the older patient
1University of Wisconsin, Madison, USA.
Geriatrics
|August 19, 1999
Summary
Clinicians should evaluate abnormal thyroid-stimulating hormone (TSH) levels in older adults, distinguishing between nonthyroidal illness and reversible medication effects. Treatment decisions depend on thyroid hormone levels and symptom persistence, with follow-up crucial for all patients.
Area of Science:
- Endocrinology
- Geriatric Medicine
- Internal Medicine
Background:
- Abnormal thyroid-stimulating hormone (TSH) values are common in older adults.
- Distinguishing true thyroid dysfunction from transient changes is clinically important.
Purpose of the Study:
- To outline a diagnostic and management approach for older patients with abnormal TSH levels.
- To guide clinicians in interpreting TSH results in the context of nonthyroidal illness and medication effects.
Main Methods:
- Clinical evaluation of older patients presenting with abnormal TSH.
- Assessment of circulating thyroid hormone levels (e.g., free T4, T3).
- Consideration of nonthyroidal illness and medication history.
Main Results:
- Abnormal TSH may stem from nonthyroidal illness or reversible medication effects.
- Patients with confirmed thyroid dysfunction and abnormal hormone levels typically require therapy.
- Those with normal hormone levels may benefit from a monitored therapeutic trial if symptomatic.
Conclusions:
- A systematic approach is necessary for managing abnormal TSH in the elderly.
- Biochemical monitoring is essential for patients not immediately requiring treatment.
- Subclinical thyroid dysfunction necessitates ongoing follow-up.
Related Concept Videos
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...